Xtant Medical Holdings (XTNT) EBITDA Margin Growth (1y) (2011 - 2025)
Xtant Medical Holdings (XTNT) EBITDA Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 146.00 |
| 10 | Xtant Medical Holdings | 45.04 Mn | 27.44 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2,116.00 |
| Jun 30, 2025 | 2,290.00 |
| Mar 31, 2025 | 1,568.00 |
| Dec 31, 2024 | 757.00 |
| Sep 30, 2024 | 1.00 |
| Jun 30, 2024 | -296.00 |
| Mar 31, 2024 | -367.00 |
| Dec 31, 2023 | -225.00 |
| Sep 30, 2023 | -39.00 |
| Jun 30, 2023 | 163.00 |
| Mar 31, 2023 | 536.00 |
| Dec 31, 2022 | 229.00 |
| Sep 30, 2022 | -265.00 |
| Jun 30, 2022 | -523.00 |
| Mar 31, 2022 | -1,410.00 |
| Dec 31, 2021 | -1,529.00 |
| Sep 30, 2021 | -1,591.00 |
| Jun 30, 2021 | 40.00 |
| Mar 31, 2021 | 921.00 |
| Dec 31, 2020 | 359.00 |